Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

349 results about "Pace maker" patented technology

What Is a Pacemaker - Pacemakers. A pacemaker is a small device that's placed in the chest or abdomen to help control abnormal heart rhythms. This device uses electrical pulses to prompt the heart to beat at a normal rate. Pacemakers are used to treat arrhythmias (ah-RITH-me-ahs).

Remotely enabled pacemaker and implantable subcutaneous cardioverter/defibrillator system

Subcutaneous Implantable cardioverter-defibrillators (SubQ ICDS) are disclosed that are entirely implantable subcutaneously with minimal surgical intrusion into the body of the patient and provide distributed cardioversion-defibrillation sense and stimulation electrodes for delivery of cardioversion-defibrillation shock and pacing therapies across the heart when necessary. The SubQ ICD is implemented with other implantable and external medical devices and communicates to provide drugs and therapy in a coordinated and synergistic manner.
Owner:MEDTRONIC INC

Methods and apparatus for controlling a pacing system in the presence of EMI

Pacing systems are disclosed including detectors for detecting the presence of electromagnetic interference and setting an interference state pacing mode and pacing rate. The interference state pacing mode and pacing rate are altered as a function of patient pacemaker dependency and the prevailing mean heart rate. When pacemaker dependency exists, the pacing rate is maintained and even increased from the prevailing mean heart for the duration of the interference state. When the patient is determined to not be pacemaker dependent, pacing is inhibited or suspended for the duration of the interference state.
Owner:MEDTRONIC INC

Method and apparatus for treating hemodynamic disfunction

A method of treating hemodynamic disfunction by simultaneously pacing both ventricles of a heart. At least one ECG amplifier is arranged to separately detect contraction of each ventricle and a stimulator is then activated for issuing stimulating pulses to both ventricles in a manner to assure simultaneous contraction of both ventricles, thereby to assure hemodynamic efficiency. A first ventricle is stimulated simultaneously with contraction of a second ventricle when the first fails to properly contract. Further, both ventricles are stimulated after lapse of a predetermined A-V escape interval. One of a pair of electrodes, connected in series, is placed through the superior vena cava into the right ventricle and a second is placed in the coronary sinus about the left ventricle. Each electrode performs both pacing and sensing functions. The pacer is particularly suitable for treating bundle branch blocks or slow conduction in a portion of the ventricles.
Owner:MIROWSKI FAMILY VENTURES LLC

Control of a defibrillator and/or pacemaker

A cardiac monitoring and treatment apparatus allows a victim of a medical emergency access to a medical professional (MP) who can monitor, diagnose and treat the victim from a remote site. The apparatus includes a cardiac monitoring and treatment device (CMTD) coupled to an electronic adaptor designed to communicate with a local, first transmitting / receiving (T / R) device which, in turn, is adapted to electronically communicate with a remote, second transmitting / receiving (T / R) device used by the MP. The CMPD comprises a cardiac treatment circuit for effecting cardiac pacing and / or defibrillation and a cardiac signal circuit for receiving cardiac signals. The cardiac signals are (1) transmitted from the signal circuit to the second T / R device for evaluation by the MP, (2) the MP may transmit a control signal to the treatment circuit, and (3), in response thereto, the treatment circuit may generate one or more electrical pulses for treatment of the victim.
Owner:MATOS JEFFREY A

Cardiac and or respiratory gated image acquisition system and method for virtual anatomy enriched real time 2d imaging in interventional radiofrequency ablation or pace maker replacement procecure

The present invention refers to the field of cardiac electrophysiology (EP) and, more specifically, to image-guided radio frequency ablation and pacemaker placement procedures. For those procedures, it is proposed to display the overlaid 2D navigation motions of an interventional tool intraoperatively obtained from the same projection angle for tracking navigation motions of an interventional tool during an image-guided intervention procedure while being navigated through a patient's bifurcated coronary vessel or cardiac chambers anatomy in order to guide e.g. a cardiovascular catheter to a target structure or lesion in a cardiac vessel segment of the patient's coronary venous tree or to a region of interest within the myocard. In such a way, a dynamically enriched 2D reconstruction of the patient's anatomy is obtained while moving the interventional instrument. By applying a cardiac and / or respiratory gating technique, it can be provided that the 2D live images are acquired during the same phases of the patient's cardiac and / or respiratory cycles. Compared to prior-art solutions which are based on a registration and fusion of image data independently acquired by two distinct imaging modalities, the accuracy of the two-dimensionally reconstructed anatomy is significantly enhanced.
Owner:KONINKLIJKE PHILIPS ELECTRONICS NV

Respiratory sinus arrhythmia training system

A biofeedback training method and apparatus to increase and reinforce the respiratory sinus arrhythmia as an outcome of a breath training technique, said apparatus comprising a physiological monitoring device that provides raw physiological data to a computer having a software program that receives and utilizes the heartbeat interbeat interval information supplied by the physiological sensors, calculates such intervals after every heartbeat, computes RSA parameters from the interbeat intervals, displays raw signal instantaneous heart rate values, calculates RSA parameters in the form of graphs, compares current values of the RSA training score with currently set threshold level to generate training feedback, provides continuous audiovisual feedback to the user to reward training attempts based on results of threshold comparisons, displays a breath pacer to induce an appropriate breathing pattern, recommended by selected breathing technique, saves interbeat intervals along with the RSA parameters into a built-in database for further review of training sessions, and permits the user to make several adjustments.
Owner:MEDDORNA

Dual chamber leadless pacemaker programmer and method

Systems and methods for providing communications between an external device and first and second leadless pacemakers (LPs) located in a heart are provided. A method includes receiving first and second event messages from the first and second LPs, the first and second event messages received at different points in time at the external device, determining the signal strengths of the first and second event messages, respectively, as received at the external device, adjusting first and second LP discrimination thresholds based on the received signal strengths of the first and second event messages, respectively, and utilizing the first and second LP discrimination thresholds to identify which of the first and second LP transmits subsequent event messages, in order for the external device to independently communicate with the first and second LPs.
Owner:PACESETTER INC

Software configurable medical device platform and associated methods

The invention relates to medical devices such as pacemakers, pulse generators, cardioverter-defibrillators and the like and more particularly relates to modular and reconfigurable medical system platforms and methods of designing, testing, controlling and implementing diverse therapies, diagnostics, physiologic sensors and related instrumentation using said medical system platforms. Methods, systems and devices provide a new design platform for implantable and external medical devices such as pacemakers, defibrillators, neurostimulators, heart monitors, etc. A real-time, highly flexible system of software and hardware modules enables both prototypes and products to respond to patient and customer needs with greater design and manufacturing efficiency. Certain embodiments integrate a general-purpose processor with interface circuitry to provide a standard platform for implementing new and conventional therapies with software models rather than custom circuitry. The platform described may be used as a simulation environment, development and test platform and / or may be used as architecture for building new medical devices.
Owner:MEDTRONIC INC

Method and System For Estimating Cardiac Ejection Volume And Placing Pacemaker Electrodes Using Speckle Tracking

A method and system for estimating the volume of blood ejected from a cardiac ventricle or atrium uses ultrasound to track speckle patterns in the heart. The process utilizes the M-mode to estimate volume differences in a view of the ventricle or atrium over time using speckle pattern motion to estimate volume differences between systole and diastole. Alternatively, the ultrasound speckle tracking method may be used in combination with Doppler processing techniques or to obtain temporal flow profiles across flow cross-sectional areas, from which the flow volume is computed. The method can also measure the phase delay of motion of sites on the cardiac wall relative to each other or relative to an ECG signal.
Owner:ST JUDE MEDICAL ATRIAL FIBRILLATION DIV

Miniaturized high-density multichannel electrode array for long-term neuronal recordings

A high-density multichannel microwire electrode array is disclosed. The array can comprise a variable number of electrodes. A method of assembling the array is further disclosed. Additionally, a plurality of devices employing the array are disclosed, including an intelligent brain pacemaker and a closed loop brain machine interface.
Owner:DUKE UNIV

Dual chamber leadless pacemaker programmer and method

Systems and methods for providing communications between an external device and first and second leadless pacemakers (LPs) located in a heart are provided. A method includes receiving first and second event messages from the first and second LPs, the first and second event messages received at different points in time at the external device, determining the signal strengths of the first and second event messages, respectively, as received at the external device, adjusting first and second LP discrimination thresholds based on the received signal strengths of the first and second event messages, respectively, and utilizing the first and second LP discrimination thresholds to identify which of the first and second LP transmits subsequent event messages, in order for the external device to independently communicate with the first and second LPs.
Owner:PACESETTER INC

System and method for achieving regular slow ventricular rhythm in response to atrial fibrillation

InactiveUS20070083242A1Decrease ventricular rateEasy to adjustElectrotherapyVentricular rateAtrial cavity
A system (10) for achieving a desired cardiac rate and cardiac rhythm in response to atrial fibrillation in a heart includes an atrial fibrillation (AF) detector (40) for detecting AF. The system also includes an atrioventricular node vagal stimulator (AVN-VS) (30) for stimulating vagal nerves associated with an atrioventricular (AV) node of the heart. The system further includes an on-demand pace maker (40) for providing ventricular pacing stimulation to the heart. A control unit (20) is operatively connected with the AF detection device, the AVN-VS device, and the on-demand pacing device. The control unit is responsive to AF detection by the AF detector to cause the AVN-VS to stimulate the vagal nerves to help reduce the ventricular rate of the heart. The control unit is further responsive to AF detection by the AF detector to cause the on-demand pace maker to help regulate the ventricular rate of the heart.
Owner:THE CLEVELAND CLINIC FOUND

Biological pacemaker

Disclosed are methods and systems for modulating electrical behavior of cardiac cells. Preferred methods include administering a polynucleotide or cell-based composition that can modulate cardiac contraction to desired levels, i.e., the administered composition functions as a biological pacemaker.
Owner:THE JOHN HOPKINS UNIV SCHOOL OF MEDICINE

Bayesian discriminator for rapidly detecting arrhythmias

A method for accurate and rapid automated detection of atrial fibrillation (AF), sinus rhythm (SF), and atrial flutter (AFL) is disclosed, which allows distinguishing of these cardiac signals with lowered risk of errors by implanted pacemakers and like devices. The method includes training episodes of intra-cardiac signals (called the closed data set CDS) to evaluate five feature parameters with a discriminator classifying the signal into AF, AFL or sinus rhythm (SR). Comparison with the independent decisions of experienced physicians for each episode reveals specificity, accuracy and sensitivity of greater than 97%. Each episode is a window of intracardiac signal of interval 1-2 seconds with the discriminator providing results in less than 0.25 s. In another aspect, the method is resistant to the presence of noise in the data. In yet another aspect, more feature parameters may be used in alternative implementations including for detecting signals other than AF, AFL & SR.
Owner:HONG KONG THE UNIV OF

Diagnostic features in biatrial and biventricular pacing systems

A biatrial and / or biventricular pacing system is used in a diagnostic context. By placing a pacing / sensing lead in three or four chambers of the heart, various conduction sequences can be determined and the originating chamber of various arrhythmias can be identified. This information is stored temporarily in the pacemaker until it is extracted for analysis.
Owner:MEDTRONIC INC

Lead adaptor having low resistance conductors and/or encapsulated housing

An implantable lead adaptor is disclosed that includes an encapsulated thermoplastic housing defining a proximal end portion and a distal end portion. The proximal end portion has a first receptacle configured to receive a first type of connector assembly associated with a first implantable cardiac lead, and a second receptacle configured to receive a second type of connector assembly associated with a second implantable cardiac lead. An elongated flexible lead portion extends from the distal end portion of the adaptor housing. A connector assembly is operatively associated with a distal end section of the flexible lead portion of the adaptor for connection to an implantable pulse-generating device, such as, for example, an implantable pacemaker or defibrillator. Low resistance conductor wires electrically connect the connector assembly associated with the distal end section of the lead portion with the first and second receptacles of the adaptor housing.
Owner:OSCOR

Suppression of high rate pacing for reducing myocardial ischemic irritability

A medical device capable of delivering automatic rate-adjusting pacing therapies is provided having an adjustable upper rate limit responsive to an indication of myocardial irritability. The device, which may be embodied as a pacemaker, a pacemaker / cardioverter / defibrillator, or the like, responds to the detection of an arrhythmia as an indicator of myocardial irritability by adjusting an upper rate limit. The adjusted upper rate limit is applied as the maximum allowable pacing rate during delivery of any pacing therapies previously defined as “long-term” pacing therapies.
Owner:MEDTRONIC INC

Core body temperature monitoring in heart failure patients

An implanted heart monitor includes sensors that measure various aspects of the heart failure patient's heart. A remote heart monitoring system connects the implanted heart monitor to a care provider, such as a physician. The data provided by the implanted heart monitor permits the care provider to obtain valuable data on the heart in order to make health care decisions affecting the heart failure patient's treatment. In many cases, the measurement of core body temperature and other patient data will enable the care provider to alter the patient's treatment to address the patient's condition. The implanted heart monitor can communicate over a wireless communication link with an external monitor. The implanted heart monitor may be implemented as part of a pacing device (i.e., pace maker) or may be a separate unit devoted to monitoring functions. The external monitor communicates with a monitoring station over a communication link. The monitoring station can operate as a centralized data collection unit, collecting data from multiple external monitors and multiple implanted heart monitors. Various other aspects of a heart failure patient's heart and / or body can be monitored, such as heart rate, blood pH levels, blood CO2 levels, and any other indications of the heart failure patient's activity. Various predetermined thresholds may be set to trigger alarms and / or data reports.
Owner:CARDIAC PACEMAKERS INC

Command sequencing and interlocks for a remotely programmable implantable device

A care provider is able to remotely program a pacemaker, drug pump, neurostimulation device or other an implantable medical device (IMD) by operating a browser application communicating with a server. Following successful authentication to the server, the care provider's browser receives information about one or more operating parameters of the IMD from the server. The care provider provides an instruction from the browser application to the server to modify one or more operating parameters. The server formats a digital program request from the instruction that includes a digital signature or other identification code uniquely identifying the server. The digital program request is then forwarded to the IMD via a remote monitor (IRM) for subsequent verification of the digital identification code and wireless transmission the verified digital program request from the IRM to the IMD.
Owner:MEDTRONIC INC

Chaos-based detection of atrial fibrillation using an implantable medical device

InactiveUS20110152957A1Mitigating detection problemReduce decreaseElectrocardiographyHeart defibrillatorsCardiac monitoringEctopic beat
Techniques are provided for detecting atrial fibrillation (AF) based on variations in ventricular intervals detected by a pacemaker, implantable cardioverter-defibrillator (ICD) or implantable cardiac monitor (ICM). In one example, ventricular beats are detected and intervals between the ventricular beats are measured, such as RR intervals. Irregular ventricular beats are identified, including ectopic beats, bigeminal beats, and the like. The degree of variability within the ventricular intervals is then determined while excluding any intervals associated with irregular beats. AF is then detected based on the degree of variability. That is, AF is detected based on variability occurring within ventricular intervals after ectopic beats and other irregular beats have been eliminated, thus mitigating detection problems that might arise if the variability were instead calculated based on all ventricular beat intervals. Techniques are also described herein for distinguishing AF from sinus tachycardia, which can also cause a high degree of variability in RR intervals.
Owner:PACESETTER INC

Recordable macros for pacemaker follow-up

A device and method for programming an implantable pulse generator. In one embodiment, commands are entered designating implantable pulse generator programming variables into programmer memory. At least some of the commands are transformed into an executable macro. The macro is stored in the programmer memory. The macro is executed to transmit the programming variables to the implantable pulse generator.
Owner:CARDIAC PACEMAKERS INC

Rest phase heart pacing

A computer method, employable during an at-rest period of a pacemaker patient, for controlling the operation of the pacemaker so as maximally to support the patient's hemodynamic behavior in a context involving inhibiting fluid overload. The method involves (a) collecting simultaneously occurring ECG and heart-sound information, (b) processing the collected information to obtain at least S3 data, and in certain instances also EMAT and / or % LVST data, (c) utilizing such obtained data, and during the at-rest period, applying (a) pacing rate, (b) pacing intensity, (c) atrio-ventricular delay, and (d) inter-ventricular delay control to the pacemaker. Processing involves (a) calculating from the obtained data an actual, real-time, acoustic cardiographic therapy (AC) value which is to be employed in relation to controlling pacemaker activity, and (b) comparing the actual AC value to a pre-established, related, rest-period-associated, reference AC value to detect differences therebetween, with the utilizing and applying steps being implemented so as to minimize such differences.
Owner:INOVISE MEDICAL

System and method for detecting and treating cardiovascular disease

InactiveUS20120046528A1Reduce resistanceElectrical resistance through the chest cavity decreasesEvaluation of blood vesselsCatheterCongestive heart failure chfCardiovascular Disorder
A system for detecting and treating congestive heart failure includes an implantable module, such as a pacemaker, and a patient advisory module. The system is configured to measure thoracic impedance and to provide the patient with instructions in order to improve the accuracy of the thoracic impedance measurement as well as treating symptoms of congestive heart failure.
Owner:PACESETTER INC

Cardiac stimulating apparatus having a blood clot filter and atrial pacer

InactiveUS20050004641A1Decrease and eliminate formationHeart defibrillatorsInternal electrodesThrombusAppendage
An apparatus is provided for reducing the formation and migration of blood clots from an atrial appendage, such as the left atrial appendage, to the blood vessel system of a patient. The apparatus comprises an atrial pacer to treat non-rheumatic atrial fibrillation (NRAF) of an atrial appendage so that the formation blood clots within the atrial appendage is decreased or eliminated. In addition, the apparatus includes a blood clot filter supported by the atrial pacer proximate the atrial appendage and the atrium to reduce the migration of blood clots from the atrial appendage into the blood vessel system of a patient.
Owner:PAPPU RAMESH

System for patient alerting associated with a cardiac event

A system for the detection of cardiac events occurring in a human patient is provided. At least two electrodes are included in the system for obtaining an electrical signal from a patient's heart. An electrical signal processor is electrically coupled to the electrodes for processing the electrical signal and a patient alarm is further provided and electrically coupled to the electrical signal processor. The patient alarm generates an escalating sensory alarm signal over a predetermined time period subsequent to the electrical signal processor if the processor detects a cardiac event. The patient alarm may be further applied to a pacemaker or defibrillator system.
Owner:ANGEL MEDICAL SYST

Surgial mesh implants containing poly(butylene succinate) and copolymers thereof

Resorbable implants comprising poly(butylene succinate) and copolymers thereof have been developed. The implants implants are preferably sterilized, and contain less than 20 endotoxin units per device as determined by the limulus amebocyte lysate (LAL) assay, and are particularly suitable for use in procedures where prolonged strength retention is necessary, and can include one or more bioactive agents. The implants may be made from fibers and meshes of poly(butylene succinate) and copolymers thereof, or by 3d printing, and the fibers may be oriented. Coverings and receptacles made from forms of poly(butylene succinate) and copolymers thereof have also been developed for use with cardiac rhythm management devices and other implantable devices. These coverings and receptacles may be used to hold, or partially / fully cover, devices such as pacemakers and neurostimulators. The coverings and receptacles are made from meshes, webs, lattices, non-wovens, films, fibers, and foams, and contain antibiotics such as rifampin and minocycline.
Owner:TEPHA INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products